The use of central venous catheters as permanent vascular access in ch
ronic hemodialysis is complicated by clotting. We have tried a nonalle
rgenic thrombolytic agent, tissue plasminogen activator (t-PA), to dis
solve catheter luminal thrombosis. Eight patients, 7 in chronic hemodi
alysis and 1 treated by immune adsorption had 18 treatments with local
ly applied t-PA (2 mg/2 cm3). Fifteen out of 16 treatments with longer
bolus dwell than 60 min were successful. No side effects occurred. t-
PA dissolves clot formation efficiently and safely, the drug is nonall
ergenic and can therefore be given repeatedly.